Sign In
Buy CVM
$1.22
-0.160 (-11.59%)
At Close: Jul 13, 2026
CEL-SCI Raises Previously-Announced Bought Deal For ~630.5K Common Shares At $12.22/Share
01:29pm, Tuesday, 24'th Mar 2020CEL-SCI Increases Previously Announced Bought Deal to $7.7 Million
01:25pm, Tuesday, 24'th Mar 2020
CEL-SCI increases previously announced bought deal to $7.7 million
CEL-SCI Corp Files Preliminary Prospectus Supplement Related To Common Stock Offering; Size Undisclosed
10:27am, Tuesday, 24'th Mar 2020CEL-SCI Announces Bought Deal Offering
01:46am, Tuesday, 24'th Mar 2020
CEL-SCI announces bought deal offering.
Healthcare firms announce Covid-19-related actions
01:15pm, Monday, 23'rd Mar 2020
The following healthcare companies have announced actions related to the COVID-19 outbreak:Coventrus (NASDAQ:CVET): seeing strong demand for prescription management and online pharmacy services.Parall
CEL-SCI to Develop LEAPS COVID-19 Immunotherapy in Collaboration with University of Georgia Center for Vaccines and Immunology
01:00pm, Monday, 23'rd Mar 2020
CEL-SCI to Develop LEAPS COVID-19 Immunotherapy in Collaboration with University of Georgia Center for Vaccines and Immunology
Weekly Biotech Update After WHO Declares Coronavirus a Pandemic
03:34pm, Friday, 13'th Mar 2020
Several pharma/companies are working to develop a treatment for novel coronavirus as WHO declares Covid-19 a pandemic.
Hot Topics Recap: Coronavirus
12:08pm, Wednesday, 11'th Mar 2020
Recap of stories on Business Wire related to Coronavirus
108 Biggest Movers From Yesterday
09:34am, Wednesday, 11'th Mar 2020
Gainers
Cypress Semiconductor Corporation (NASDAQ: CY) shares jumped 48.9% to close at $22.75 on Tuesday after the company received clearance from the Committee on Foreign...
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Levi & Korsinsky announces it has commenced an investigation of CEL-SCI Corporation (NYSE:CVM) concerning possible breaches of fiduciary duty. To obtain ad
CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection
11:55am, Monday, 09'th Mar 2020
CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection.
CEL-SCI Shares Lower, Seeing Short Report On Stock Alleging Fraud
12:00am, Monday, 09'th Mar 2020Oil stocks continue losing streak amid coronavirus fears
05:44pm, Thursday, 27'th Feb 2020
Oil stocks are extend their losing streak into day five as fears of the coronavirus continue. Blue Line Futures President Bill Baruch joins Yahoo Finance’s On the Move to discuss.
